David J. Blanchard

Array ( [id] => 5309740 [patent_doc_number] => 20090017021 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-15 [patent_title] => 'Methods and compositions for inducing innate immune responses' [patent_app_type] => utility [patent_app_number] => 12/148275 [patent_app_country] => US [patent_app_date] => 2008-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 22381 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0017/20090017021.pdf [firstpage_image] =>[orig_patent_app_number] => 12148275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4812835 [patent_doc_number] => 20080193466 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-14 [patent_title] => 'Treatment of Anemia Using TNFalpha Inhibitors' [patent_app_type] => utility [patent_app_number] => 12/102682 [patent_app_country] => US [patent_app_date] => 2008-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19832 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20080193466.pdf [firstpage_image] =>[orig_patent_app_number] => 12102682 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5445987 [patent_doc_number] => 20090047213 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-19 [patent_title] => 'Cytotoxicity mediation of cells evidencing surface expression of CD59' [patent_app_type] => utility [patent_app_number] => 12/082659 [patent_app_country] => US [patent_app_date] => 2008-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 28160 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20090047213.pdf [firstpage_image] =>[orig_patent_app_number] => 12082659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4710589 [patent_doc_number] => 20080299115 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-04 [patent_title] => 'Antibody Variants with Faster Antigen Association Rates' [patent_app_type] => utility [patent_app_number] => 12/061551 [patent_app_country] => US [patent_app_date] => 2008-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 21785 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20080299115.pdf [firstpage_image] =>[orig_patent_app_number] => 12061551 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4873920 [patent_doc_number] => 20080200654 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-21 [patent_title] => 'ANTI-A33 ANTIBODY' [patent_app_type] => utility [patent_app_number] => 12/053461 [patent_app_country] => US [patent_app_date] => 2008-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 36832 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20080200654.pdf [firstpage_image] =>[orig_patent_app_number] => 12053461 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5289928 [patent_doc_number] => 20090022658 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'MODIFIED ANTIBODIES AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/032424 [patent_app_country] => US [patent_app_date] => 2008-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 20901 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20090022658.pdf [firstpage_image] =>[orig_patent_app_number] => 12032424 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4752532 [patent_doc_number] => 20080160607 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'DNA CONSTRUCT ENCODING CE7-SPECIFIC CHIMERIC T CELL RECEPTOR' [patent_app_type] => utility [patent_app_number] => 12/028442 [patent_app_country] => US [patent_app_date] => 2008-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 15780 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20080160607.pdf [firstpage_image] =>[orig_patent_app_number] => 12028442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4675660 [patent_doc_number] => 20080213289 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'RECOMBINANT ANTI-CD30 ANTIBODIES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/016978 [patent_app_country] => US [patent_app_date] => 2008-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 41103 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20080213289.pdf [firstpage_image] =>[orig_patent_app_number] => 12016978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4965886 [patent_doc_number] => 20080108706 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-08 [patent_title] => 'Chemical resection of pancreas' [patent_app_type] => utility [patent_app_number] => 12/003735 [patent_app_country] => US [patent_app_date] => 2007-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7986 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20080108706.pdf [firstpage_image] =>[orig_patent_app_number] => 12003735 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4928095 [patent_doc_number] => 20080167458 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-10 [patent_title] => 'ANTI-CD33 ANTIBODIES AND METHOD FOR TREATMENT OF ACUTE MYELOID LEUKEMIA USING THE SAME' [patent_app_type] => utility [patent_app_number] => 11/961256 [patent_app_country] => US [patent_app_date] => 2007-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 18396 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20080167458.pdf [firstpage_image] =>[orig_patent_app_number] => 11961256 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4791600 [patent_doc_number] => 20080292573 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'Method for treating hair with a reactive vinyl silicone capable of reacting via hydrosilylation' [patent_app_type] => utility [patent_app_number] => 12/000886 [patent_app_country] => US [patent_app_date] => 2007-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6212 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20080292573.pdf [firstpage_image] =>[orig_patent_app_number] => 12000886 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4823646 [patent_doc_number] => 20080227957 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'Reducing Immunogenicities of Immunoglobulins by Framework-Patching' [patent_app_type] => utility [patent_app_number] => 11/950878 [patent_app_country] => US [patent_app_date] => 2007-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 12300 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20080227957.pdf [firstpage_image] =>[orig_patent_app_number] => 11950878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 348965 [patent_doc_number] => 07495081 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-24 [patent_title] => 'Framework patched anti-CD20 antibody' [patent_app_type] => utility [patent_app_number] => 11/950894 [patent_app_country] => US [patent_app_date] => 2007-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 17 [patent_no_of_words] => 12317 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/495/07495081.pdf [firstpage_image] =>[orig_patent_app_number] => 11950894 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4825749 [patent_doc_number] => 20080124765 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-29 [patent_title] => 'EXPRESSION OF FUNCTIONAL ANTIBODY FRAGMENTS' [patent_app_type] => utility [patent_app_number] => 11/944406 [patent_app_country] => US [patent_app_date] => 2007-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14463 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20080124765.pdf [firstpage_image] =>[orig_patent_app_number] => 11944406 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4825689 [patent_doc_number] => 20080124739 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-29 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR' [patent_app_type] => utility [patent_app_number] => 11/943454 [patent_app_country] => US [patent_app_date] => 2007-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 66001 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20080124739.pdf [firstpage_image] =>[orig_patent_app_number] => 11943454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5514116 [patent_doc_number] => 20090214422 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => ' DNA encoding a novel RG1 polypeptide' [patent_app_type] => utility [patent_app_number] => 11/981240 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 28959 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20090214422.pdf [firstpage_image] =>[orig_patent_app_number] => 11981240 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 216798 [patent_doc_number] => 07611706 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-03 [patent_title] => 'RG1 antibodies and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/981219 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17564 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/611/07611706.pdf [firstpage_image] =>[orig_patent_app_number] => 11981219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 220647 [patent_doc_number] => 07608263 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-27 [patent_title] => 'RG1 antibodies and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/981123 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17552 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/608/07608263.pdf [firstpage_image] =>[orig_patent_app_number] => 11981123 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4456920 [patent_doc_number] => 07893217 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-22 [patent_title] => 'Isolated human antibodies that bind epitopes on RG1' [patent_app_type] => utility [patent_app_number] => 11/981132 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 10 [patent_no_of_words] => 28963 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/893/07893217.pdf [firstpage_image] =>[orig_patent_app_number] => 11981132 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4675540 [patent_doc_number] => 20080213169 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'Cytotoxicity mediation of cells evidencing surface expression of CD59' [patent_app_type] => utility [patent_app_number] => 11/975781 [patent_app_country] => US [patent_app_date] => 2007-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 27356 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20080213169.pdf [firstpage_image] =>[orig_patent_app_number] => 11975781 [rel_patent_id] =>[rel_patent_doc_number] =>)